EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Sweet Aspects of Orthoflavivirus Treatment Design and Vaccine Development

Ana C Alcalá iD, Michelle Gutiérrez iD, Juan E Ludert iD

Journal of Medical Virology · 2025-10 · 97 (10)

DOI: 10.1002/jmv.70637 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, online erschienen am 09.10.2025. Verfasst von Ana C Alcalá und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (Cinvestav), Mexico City, Mexico. Hauptthemen laut MEDLINE: Vaccine Development, Viral Vaccines, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viruses in the genus Orthoflavivirus are among the most important human pathogens because of their significant public health impact. Many strategies have been proposed to develop specific or broad‐spectrum treatments and preventive measures for these viral infections in humans. One of the most promising targets for developing treatments or vaccines is glycan molecules, found on both viral and host proteins, which are essential during the infectious cycle. This review examines various antiviral and immunization approaches focused on glycoproteins to fight orthoflavivirus infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccine DevelopmentViral VaccinesAntiviral AgentsHumansAnimalsGlycoproteins

Stichwörter der Autor:innen

N‐glycosylationOrthoflavivirusZikaantiviral designdenguevaccine development

Substanzen

Viral VaccinesAntiviral AgentsGlycoproteins

Autor:innen und Institutionen

  • Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies (Cinvestav), Mexico City, Mexico.
  • Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, México.

ORCID-Profile: Ana C Alcalá, Michelle Gutiérrez, Juan E Ludert

Zitieren

APA

Alcalá, A. C., Gutiérrez, M., & Ludert, J. E. (2025). The Sweet Aspects of Orthoflavivirus Treatment Design and Vaccine Development. Journal of Medical Virology, 97(10). https://doi.org/10.1002/jmv.70637

Vancouver

Alcalá AC, Gutiérrez M, Ludert JE. The Sweet Aspects of Orthoflavivirus Treatment Design and Vaccine Development. Journal of Medical Virology. 2025;97(10). doi:10.1002/jmv.70637

BibTeX
@article{Alcal2025,
  author = {Alcalá, Ana C and Gutiérrez, Michelle and Ludert, Juan E},
  title = {The Sweet Aspects of Orthoflavivirus Treatment Design and Vaccine Development},
  journal = {Journal of Medical Virology},
  year = {2025},
  volume = {97},
  number = {10},
  doi = {10.1002/jmv.70637}
}
Kostenlos starten →